Carazolol, an extremely potent beta-adrenergic blocker: binding to beta-receptors in brain membranes.
D000319:Adrenergic beta-Antagonists / Q000097:blood / Q000378:metabolism*; D000818:Animals; D001798:Blood Proteins / Q000378:metabolism; D001921:Brain / Q000378:metabolism*; D002227:Carbazoles / Q000097:blood / Q000378:metabolism*; D004082:Dihydroalprenolol / Q000378:metabolism; D007700:Kinetics; D008297:Male; D008566:Membranes / Q000378:metabolism; D011412:Propanolamines / Q000097:blood / Q000378:metabolism*; D011485:Protein Binding; D051381:Rats; D011941:Receptors, Adrenergic / Q000378:metabolism*; D011943:Receptors, Adrenergic, beta / Q000378:metabolism*
D000319:Adrenergic beta-Antagonists; D001798:Blood Proteins; D002227:Carbazoles; D011412:Propanolamines; D011941:Receptors, Adrenergic; D011943:Receptors, Adrenergic, beta; C014382:carazolol; D004082:Dihydroalprenolol